• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 4. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives

Market Research and Analysis of 1-Bromo-1,1-difluoro-4-phenylbutan-2-one (CAS No. 862457-93-0) in the Chemical-Biomedical Field

1-Bromo-1,1-difluoro-4-phenylbutan-2-one, identified by the CAS registry number 862457-93-0, is a specialized chemical compound with potential applications in the chemical-biomedical field. This compound has garnered attention due to its unique structural properties and its potential role in drug development and related research activities.

The compound's structure, featuring a bromine atom, two fluorine atoms, and a phenyl group attached to a butanone backbone, suggests its utility in various synthetic pathways. Recent studies have highlighted its potential as an intermediate in the synthesis of bioactive molecules, particularly in the context of drug discovery and development.

Market demand for such specialized compounds is driven by the increasing focus on novel therapeutic agents and the need for high-quality intermediates in pharmaceutical research. The global pharmaceutical industry's emphasis on innovation has further fueled the demand for such compounds, particularly in regions with robust research and development (R&D) infrastructure.

From a supply chain perspective, key suppliers of 1-Bromo-1,1-difluoro-4-phenylbutan-2-one are concentrated in regions with advanced chemical manufacturing capabilities. These suppliers cater to both academic research institutions and commercial entities engaged in drug development. The competitive landscape is characterized by a balance between established players and emerging suppliers who leverage cutting-edge synthetic methodologies to meet market demands.

In terms of procurement trends, there is a growing preference for suppliers offering high-purity grades of this compound, as well as those providing customized synthesis services. Additionally, sustainability considerations are increasingly influencing procurement decisions, with buyers favoring suppliers who adhere to environmentally friendly manufacturing practices.

The compound's application extends beyond pharmaceuticals; it also finds use in biotechnological research and as a precursor in the synthesis of advanced materials. Its versatility underscores its importance in diverse research domains within the chemical-biomedical field.

In conclusion, 1-Bromo-1,1-difluoro-4-phenylbutan-2-one (CAS No. 862457-93-0) occupies a niche yet significant position in the chemical-biomedical market. Its demand is driven by ongoing research activities and the need for high-quality intermediates in drug development. As the industry continues to evolve, the availability of this compound from reliable suppliers will remain critical to sustaining innovation and progress in this field.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)